Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Starkey Laboratories Inc.

Latest From Starkey Laboratories Inc.

Market Intel: Hearing-Aid Companies' Use Of AI, Apps, New Tech Excites Audiologists; Global Hearing-Aid Market Will Reach $11Bn By 2023

Hearing-aid manufacturers are using AI, apps and other new technologies to create devices that are more sophisticated, smaller and more programmable. According to a new report by Informa's Meddevicetracker, the global market for hearing aids will reach $11by by 2023. This article offers an in-depth look at the competitive landscape, products as well as trends, such as new US FDA regulations for over-the-counter hearing aids and devices with language translation capabilities, with key insights from two audiologists.

Ear Market Intelligence

Five Charged In $20m Embezzlement At Hearing Aid Company

Three former executives at hearing aid company Starkey Laboratories, along with two outside conspirators, are facing federal fraud, conspiracy and money-laundering charges. The defendants reportedly stole more than $20m via a complicated web of sham companies between 2006 and 2015.

United States Commercial

Drugs for Hearing Loss: A Sound Opportunity

Hearing loss is an arena largely ignored by the biopharmaceutical industry, with most of the innovation coming from med-tech players. That situation is ripe for change as a vanguard of start-ups is attempting to develop novel therapies to treat a variety of hearing disorders, including Ménière's disease and sudden sensorineural hearing loss.
BioPharmaceutical Business Strategies

Rumblings of Change in the Hearing Markets: Sonova Buys Advanced Bionics

The hearing markets have followed a different evolutionary branch than the rest of the medical world, with a complicated infrastructure, and a schism between its two main product categories; the hearing aids sold through the audiology channel, and cochlear implants, surgical devices marketed to ENTs. This fragmentation has long kept the hearing markets from realizing their potential. The recent merger of Advanced Bionics with Sonova is a major step toward bridging the chasm in the hearing impairment industry, and perhaps in beginning to change its dynamics.
Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Otolaryngology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Starkey Laboratories Inc.
  • Senior Management
  • Bill Austin, CEO
  • Contact Info
  • Starkey Laboratories Inc.
    Phone: (952) 941-6401
    6700 Washington Ave. S.
    Eden Prairie, MN 55344